96 related articles for article (PubMed ID: 7031298)
21. Immunostimulant activity in conformationally constrained analogues of MDP.
Kundu B; Rizvi SY; Haq W; Saxena RP; Saxena KC; Mathru KB
Indian J Biochem Biophys; 1987 Jun; 24(3):129-32. PubMed ID: 3428910
[No Abstract] [Full Text] [Related]
22. Activation of the alternative pathway of complement by mycobacteria and cord factor.
Ramanathan VD; Curtis J; Turk JL
Infect Immun; 1980 Jul; 29(1):30-5. PubMed ID: 6995341
[TBL] [Abstract][Full Text] [Related]
23. [Stimulation of polymorphonuclear leukocytes by bacterial cell wall components and related synthetic compounds].
Ishihara Y
J Osaka Univ Dent Sch; 1981 Jun; 26(1):105-20. PubMed ID: 6945420
[No Abstract] [Full Text] [Related]
24. Enhancement of endotoxic shock by N-acetylmuramyl-L-alanyl-(L-seryl)-D-isoglutamine (muramyl dipeptide).
Ribi EE; Cantrell JL; Von Eschen KB; Schwartzman SM
Cancer Res; 1979 Nov; 39(11):4756-9. PubMed ID: 115579
[TBL] [Abstract][Full Text] [Related]
25. [Cancer immunotherapy with BCG cell-wall skeleton (author's transl)].
Azuma I; Yamamura Y
Tanpakushitsu Kakusan Koso; 1978 May; 23(6):625-40. PubMed ID: 211546
[No Abstract] [Full Text] [Related]
26. [Adjuvant activity and adjuvant arthritis].
Tanaka A
Kekkaku; 1980 Oct; 55(10):465-7. PubMed ID: 7230587
[No Abstract] [Full Text] [Related]
27. [Immunity against cancer--a critical review of recent progress--].
Yamamura Y
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):311-9. PubMed ID: 6192758
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant and antitumor activities of quinonyl-N-acetylmuramyldipeptides.
Azuma I; Yamawaki M; Uemiya M; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Imada I; Yamamura Y
Gan; 1979 Dec; 70(6):847-8. PubMed ID: 535688
[No Abstract] [Full Text] [Related]
29. Adjuvant activity of 6-amino-6-deoxy-muramyldipeptides and their acylamino derivatives on the induction of delayed hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.
Azuma I; Okumura H; Saiki I; Tanio Y; Kiso M; Hasegawa A; Yamamura Y
Infect Immun; 1981 Jun; 32(3):1305-8. PubMed ID: 7251169
[TBL] [Abstract][Full Text] [Related]
30. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.
Chedid L; Carelli C; Audibert F
J Reticuloendothel Soc; 1979 Dec; 26(Suppl):631-41. PubMed ID: 392087
[No Abstract] [Full Text] [Related]
31. [Fundamental studies to use the adjuvant activity of 6-o-acylmuramyldipeptides to potentiate cell and humoral immune responses for practical purposes].
Tsujimoto M
J Osaka Univ Dent Sch; 1981 Jun; 26(1):63-83. PubMed ID: 6945426
[No Abstract] [Full Text] [Related]
32. [Biochemical and immunological properties of the fractions of tubercle bacilli].
Azuma I
Kekkaku; 1998 Feb; 73(2):65-70. PubMed ID: 9545698
[TBL] [Abstract][Full Text] [Related]
33. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
34. [Activation of macrophage by bacterial cell wall peptidoglycans and muramyl dipeptides].
Nagao S
Nihon Saikingaku Zasshi; 1987 Nov; 42(6):801-15. PubMed ID: 3448257
[No Abstract] [Full Text] [Related]
35. Recent advances concerning the use of muramyl dipeptide derivatives as vaccine potentiators.
Audibert F; Chedid L
Prog Clin Biol Res; 1980; 47():325-38. PubMed ID: 7010376
[No Abstract] [Full Text] [Related]
36. Immunoadjuvant activities of peptidoglycan subunits from the cell walls of Staphyloccus aureus and Lactobacillus plantarum.
Kotani S; Watanabe Y; Shimono T; Kinoshita F; Narita T
Biken J; 1975 Jun; 18(2):93-103. PubMed ID: 1180873
[TBL] [Abstract][Full Text] [Related]
37. Muramyl dipeptide stimulation of particle clearance in several animal species.
Waters RV; Ferraresi RW
J Reticuloendothel Soc; 1980 Nov; 28(5):457-71. PubMed ID: 7441647
[No Abstract] [Full Text] [Related]
38. Relationship of anti-tuberculous protection to lung granuloma produced by intravenous injection of synthetic 6-O-mycoloyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with or without specific antigens.
Yamamoto K; Kakinuma M; Kato K; Okuyama H; Azuma I
Immunology; 1980 Aug; 40(4):557-64. PubMed ID: 7000685
[TBL] [Abstract][Full Text] [Related]
39. [Structure-functional study of glycosaminylmuramoyl peptides. The effect of chemical modification of N-acetylglucosaminyl-N-acetylmuramoyldipeptide on its immunomodulating properties in vivo and in vitro].
Meshcheriakova EA; Gur'ianova SV; Makarov EA; Andronova TM; Ivanov VT
Bioorg Khim; 1991 Sep; 17(9):1157-65. PubMed ID: 1807252
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of N-acetyl-muramyl-L-alanyl-D-glutamic-alpha-amide(MDP) or -alpha-methyl ester derivatives, bearing a lipophilic group at the C-terminal peptide end.
Lefrancier P; Petitou M; Level M; Derrien M; Choay J; Lederer E
Int J Pept Protein Res; 1979; 14(5):437-44. PubMed ID: 536111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
